The Clinical and Economic Benefits Associated With Novel Multi-Cancer Early Detection Tests: Conference Highlights from the 2022 ISPOR Annual Meeting
Advertisement
Advertisement
Trending on AJMC
1
Prescription Access Crisis: 40% of GLP-1 RA Rx Are Unfilled
2
FDA Expands Upadacitinib Label for Treating Inflammatory Bowel Disease
3
New WHO Report Sounds Alarm on Antimicrobial Resistance
4
Pediatric Atopic Dermatitis Treatment Selection: Biologics vs Nonsteroidal Topical Therapies
5
